Painlessness does not make a lump safe to ignore and it does not make it cancerous either. Most painless lumps are benign. Lipomas, sebaceous cysts, fibroadenomas and reactive lymph nodes are all painless and none of them are malignant. What raises concern is not the absence of pain but the feel of the lump, where it sits, how fast it’s growing and whether it’s changing. Those four things together determine whether urgent investigation is needed, not whether it hurts.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “pain is a poor indicator of cancer. Some of the most serious lumps are completely painless. What I look at is the feel, the location and whether it’s changing. Those are the real indicators.“

Most painless lumps fit recognisable benign patterns that an experienced clinician can identify on examination and ultrasound without needing immediate biopsy.

• Soft and Mobile: Soft, smooth, freely mobile lumps with a clear tissue plane underneath are almost always lipomas and cancer diagnosis is not the clinical priority for a lump that has been stable, non-tender and completely unchanged in size for months.
• Skin Surface Lump: A lump on the skin with a visible central punctum and slow growth over years is a sebaceous cyst, a benign blocked gland that only needs removal if it repeatedly becomes infected or causes discomfort.
• Post-Infection Node: A soft lymph node appearing after a throat infection, dental abscess or skin infection is the immune system doing its job and in most cases it settles completely within two to four weeks without investigation.
• Young Woman, Breast Lump: Firm, smooth, mobile breast lumps in women under 30 are most likely fibroadenomas. Ultrasound confirms this and most are managed with observation rather than surgery unless they grow or cause concern.

Benign lumps share a pattern of softness, clear mobility and stable size over time that fits a known non-malignant diagnosis on examination.

Certain characteristics in any painless lump shift clinical priority from observation to urgent investigation.

• Hard and Doesn’t Move: A lump that feels hard, has irregular edges and resists movement when pressed is clinically concerning regardless of pain and robotic cancer surgery or conventional resection for confirmed malignancy produces far better outcomes when investigation happens promptly rather than after months of delay.
• Growing Over Weeks: Visible size increase over two to four weeks is a more reliable indicator of malignant biology than pain level ever is, and any growing lump warrants ultrasound and biopsy regardless of whether the patient feels any discomfort from it.
• High-Risk Location: Neck, axilla, breast, groin and testis carry higher malignancy probability than lumps elsewhere and any new lump in these sites in an adult over 40 needs imaging and specialist review without delay.
• Accompanying Symptoms: Weight loss, night sweats, persistent fatigue or hoarseness alongside a painless lump points toward a serious systemic or malignant cause and changes the clinical picture significantly regardless of how innocent the lump looks on the surface.

Any lump that is hard, growing, fixed or sitting in a high-risk location needs specialist assessment before a benign diagnosis is accepted and for more on how cancer is confirmed, our blog on cancer diagnosis covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to lump assessment and cancer surgery across all anatomical sites at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients with uncertain lumps wanting a clear specialist assessment before any surgical decision are seen here with every case reviewed through tumour board.
Call +91 8104310753 to book your consultation.

References

1. National Cancer Institute — Cancer Symptoms and Signs
2. World Health Organization — Cancer Early Detection

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Less painful than most patients expect. Small port incisions of 8 to 12mm replace a large open wound, meaning far less tissue damage, less muscle trauma and significantly lower post-operative inflammation. Most patients describe the experience as soreness rather than pain from day two onward. Hospital stay typically runs one to three days and light activity starts within one to two weeks depending on the procedure performed.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “patients consistently say the recovery was easier than they feared. Small incisions make a real difference to first-week pain and that directly affects how quickly they get back to adjuvant treatment.“

Pain after robotic surgery is manageable with standard oral medication for most patients and substantially lower than the same procedure performed through an open approach.

• First 48 Hours: Mild to moderate soreness at the port sites is the most common complaint immediately after the operation and robotic cancer surgery patients at KIMS Hospital are managed with paracetamol, anti-inflammatories and local port-site anaesthesia rather than heavy opioid reliance from the outset.
• Shoulder Tip Pain: Carbon dioxide used to inflate the abdomen during robotic surgery refers temporary discomfort to the shoulder tip as the gas dissipates, typically resolving within 24 to 48 hours with simple analgesia and early mobilisation after the operation.
• Port Site Soreness: The four to five small incisions remain tender for five to seven days and most patients rate this discomfort at three to four out of ten, considerably lower than the wound pain reported after equivalent open surgical procedures for the same cancer type.
• Procedure Influences Pain: Pelvic operations for rectal or prostate cancer produce more post-operative discomfort than upper abdominal procedures because of the anatomical dissection involved, and the surgical team advises specifically on expected pain levels before every operation.

Pain after robotic surgery is real but in most cases it is the least difficult part of the recovery journey compared to functional restrictions that follow.

Recovery after robotic surgery moves significantly faster than open surgery across every cancer operation where both approaches are clinically available.

• Hospital Discharge: Most patients are discharged within one to three days compared to five to seven days after open surgery and laparoscopic cancer surgery patients show similar early discharge patterns because smaller incisions support faster return of bowel function and lower infection risk from the start.
• Light Activity Returns Quickly: Walking, household activity and self-care are achievable within one to two weeks for most robotic surgery patients, with the absence of a large abdominal wound being the primary reason recovery progresses at this pace compared to open procedures.
• Full Activity and Driving: Most patients return to full normal daily activity and driving between two and four weeks after robotic surgery and are fit to begin adjuvant chemotherapy or radiation within three to four weeks rather than the six to eight weeks often required after open surgery.
• Minimal Wound Care: Port sites require simple dressing changes for five to seven days and most patients manage this independently at home, in contrast to open surgical wounds that frequently need clinical wound care attendance for two to four weeks post-operatively.

Recovery after robotic surgery is genuinely faster and more comfortable than most patients anticipate and for more on what robotic surgery costs in Bangalore, our blog on robotic surgery cost covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to robotic cancer surgery across all cancer types at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients wanting to understand what robotic surgery recovery looks like for their specific procedure are seen here with every case reviewed through tumour board. Call +91 8104310753 to book your consultation.

References

1. National Cancer Institute — Robotic Surgery in Cancer Treatment
2. World Health Organization — Minimally Invasive Surgery

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Rectal cancer is a type of cancer that begins in the rectum, and it is one of the most common forms of colorectal cancer. Early-stage rectal cancer often presents with no or subtle symptoms, making it difficult for patients to recognize the disease in its initial stages. When rectal cancer is diagnosed at an advanced stage, treatment becomes more complex, and the chances of successful recovery decrease. Therefore, early detection of rectal cancer is crucial for better treatment outcomes.

Dr. Sandeep Nayak, an ace surgical oncologist in India, states, “Catching rectal cancer early allows us to use less invasive treatments and significantly improve the chances of recovery.”

Early detection of rectal cancer involves recognizing warning signs, understanding risk factors, and seeking professional evaluation if symptoms develop. At MACS Clinic, Dr. Sandeep Nayak offers advanced rectal cancer treatment in Bangalore, combining state-of-the-art technology with personalized care. By focusing on early diagnosis, he ensures that patients receive timely intervention, which can make all the difference in the effectiveness of their treatment, improving their quality of life and long-term health.

Early-stage rectal cancer is often treatable with less aggressive interventions. When detected early, the chances of a complete recovery increase dramatically, and patients have access to a wider range of treatment options. In contrast, if rectal cancer is discovered at a later stage, it may have spread to other parts of the body, requiring more intensive treatments such as chemotherapy or radiation therapy.

Dr. Sandeep Nayak explains, “The earlier we catch rectal cancer, the more treatment options we have, and the better the prognosis.” This highlights the importance of screening and being vigilant about any changes in your health, especially if you are at higher risk.

Being aware of the symptoms associated with rectal cancer is key to early detection. While other conditions can also cause some of these signs, it’s essential to seek medical advice if they persist:

• Changes in bowel habits:

Frequent diarrhea or constipation, or a feeling that your bowel doesn’t empty completely.

• Blood in stool:

Bright red blood or dark, tarry stools can indicate bleeding in the digestive tract.

• Unexpected weight loss:

Losing weight without trying can be a sign of various cancers, including rectal cancer.

• Fatigue:

A constant state of tiredness that doesn’t improve even with rest.

• Abdominal pain:

Persistent cramps or bloating in the stomach area.

If you experience any of these symptoms for an extended period, don’t wait; consult an oncologist to rule out potential problems or catch them early.

When rectal cancer is detected early, the chances of successful treatment increase significantly. This is because early diagnosis enables:

• Less invasive surgery: Smaller tumors are easier to remove, often with minimally invasive surgery.
• Better chances of survival: Since the disease has not spread too much, the probability of surviving increases.
• Fewer complications: With early treatment, there will be less possibility of developing any complications during and after surgery.
• More options of treatment: It will be possible for the patient to choose whether to undergo surgery, chemotherapy, or radiotherapy, depending on the stage of cancer.

According to Dr. Sandeep Nayak, a distinguished surgical oncologist in Bangalore, India, “By detecting cancer early, we give patients more choices for treatment, which improves both outcomes and quality of life.”

Some factors increase the likelihood of developing rectal cancer, such as:

• Age: Risk increases after the age of 50.
• Family history: A family history of colorectal cancer or polyps increases your risk.
• Diet: High intake of red or processed meat and low fiber foods may increase your chances of getting rectal cancer.
• Personal history: History of having inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis.
• Lifestyle factors: Smoking, excessive alcohol use, and lack of physical activity.

Some risk factors can’t be changed, while others may be controlled by adopting a healthy lifestyle and staying on top of screenings, which can significantly reduce the likelihood of developing rectal cancer.

Screening tests are essential for early detection, especially for individuals at higher risk. Common tests include:

• Colonoscopy:

This procedure is highly common and one of the best screening tests used to diagnose rectal cancer and even precancerous polyps.

• Stool Tests:

Stool sample tests, such as FIT or FOBT, help detect blood in the stool, an indication of cancer.

• CT Colonography:

A non-invasive imaging test that creates detailed pictures of the colon and rectum.

• Sigmoidoscopy:

A less extensive form of colonoscopy, sigmoidoscopy, is done to examine the lower part of the colon and rectum.

Screening is highly recommended for individuals over 50 years of age or at high risk. It can detect cancer before symptoms appear, allowing for earlier and more effective treatment.

Various tips could help one prevent rectal cancer by leading a healthy lifestyle:

• Eat a healthy diet: This includes a diet rich in fruits and vegetables as well as fiber and low in red and processed meat.
• Exercise regularly: Physical activity helps you maintain a healthy weight, hence reducing the risk of cancer.
• Avoid smoking and drinking excessively: These habits will increase the risk of getting rectal cancer.
• Screening: You should screen for early detection through a colonoscopy or a stool test.
• Healthy body weight: Being obese increases the risk of cancer, so maintaining a healthy weight can reduce your risk.

According to Dr. Sandeep Nayak, “Taking simple but important steps to maintain a healthy lifestyle as well as screening often would help prevent rectal cancer.”

Reference links:

https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging.html

https://www.brownhealth.org/centers-services/colorectal-cancer-center/early-detection-colorectal-cancer-key

Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Thyroid cancer is one of the most common cancers of the endocrine system, with increasing diagnoses in both men and women globally, including in India. While thyroid cancer is relatively rare compared to other cancers, its incidence has been steadily rising, especially in urban areas. The good news is that thyroid cancer, when diagnosed early, is highly treatable with excellent survival rates.

Dr. Sandeep Nayak, a well-known surgical oncologist in India, states, “With early detection and appropriate treatment, most patients with thyroid cancer can expect a full recovery, making regular screenings and timely intervention essential.” However, the question of whether thyroid cancer can be fully cured depends on its type, stage, and the patient’s overall health.

With extensive expertise in thyroid procedures, Dr. Nayak is dedicated to guiding patients through every stage of their treatment, maximizing their chances of long-term health and recovery. He offers comprehensive thyroid cancer treatment in Bangalore, with a focus on the latest modalities and personalized care.

Having years of experience in treating complex thyroid conditions, Dr. Nayak’s approach combines advanced, minimally invasive surgical techniques with effective follow-up strategies. He ensures that every patient receives the highest level of care tailored to their individual needs.

Thyroid cancer develops when cells in the thyroid gland grow uncontrollably. The thyroid, located in the neck, produces hormones that regulate metabolism, body temperature, and heart rate.

When cancerous cells form, they can either be localized or spread to other parts of the body. Thyroid cancer is typically identified when a lump or nodule is found in the neck, often through routine exams or imaging tests.

How do different types of thyroid cancer affect the chance of a cure? Let’s look at the types.

There are four main types of thyroid cancer, and their cure rates vary:

1. Papillary Thyroid Cancer (PTC):

The most common form, making up about 80% of cases. It has an excellent prognosis with a high cure rate (over 90% if caught early).

2. Follicular Thyroid Cancer (FTC):

Less common but still treatable. It also has a good prognosis with cure rates of around 80-90%.

3. Medullary Thyroid Cancer (MTC):

A rarer type that may have a more challenging treatment course, but with early detection, the cure rate is around 70%.

4. Anaplastic Thyroid Cancer (ATC):

The most aggressive form, which is difficult to treat and has a lower cure rate, often under 10%.

Wondering about the available treatment options? Let’s dive into it

Thyroid cancer treatment depends on the type and stage of cancer, as well as the patient’s overall health. The treatment methods are:

* Surgery

This is the most common treatment method, which entails the removal of affected tissue or the entire thyroid gland.

* Radioactive Iodine Therapy

After surgery, this treatment may be used to destroy any remaining cancer cells.

* External Radiation Therapy

Radiation treatment is applied in specific cases where it targets and shrinks the tumor, especially when dealing with anaplastic cancer.

* Targeted Therapy

In cases of medullary thyroid cancer or advanced disease, targeted drugs can help inhibit cancer cell growth.

o Cancer type: Papillary and follicular thyroid cancer typically have a higher survival rate than medullary or anaplastic types.

o Stage at diagnosis: Early-stage cancer is easier to treat, hence it offers better chances of success.

o Age: Younger individuals generally have better outcomes.

o Overall health: A person’s general health status impacts recovery from cancer.

How long can patients live with thyroid cancer? Let’s find out

Survival rate for thyroid cancer largely depends on the type, stage, and the patient’s overall health. For papillary and follicular thyroid cancer, the 5-year survival rate is typically above 90%, especially when detected early and treated effectively.

Medullary thyroid cancer has a somewhat lower survival rate. It ranges from 70-80% as this type tends to be more aggressive and harder to treat. Anaplastic thyroid cancer, the rarest and most aggressive, has a much lower survival rate, often under 10%, since it spreads rapidly and is difficult to manage.

Yes, thyroid cancer can come back. Likelihood depends on various factors, such as the type of thyroid cancer, stage at diagnosis, and effectiveness of initial treatment. Papillary and follicular thyroid cancer have a relatively low recurrence rate, especially when treated early. Medullary and anaplastic may have a higher chance of recurrence.

“Recurrence can occur locally, within the thyroid bed, or even at distant sites like the lungs or bones. This is why regular follow-up care is crucial,” states Dr. Sandeep Nayak, an esteemed surgical oncologist in Bangalore. Imaging tests, blood tests to check thyroid hormone levels, and ultrasounds are commonly used to monitor for any signs of recurrence.

How can you maximize your chances of recovery? Here are some tips

• Follow your doctor’s instructions regarding post-treatment care, including medication and lifestyle changes.

• Maintain a healthy diet to support your recovery and overall well-being.
• Attend regular follow-up appointments to monitor your thyroid function and ensure cancer does not return.

• Stay active with appropriate exercise, as recommended by your doctor, to enhance recovery and prevent complications.

Reference links:

https://www.mayoclinic.org/diseases-conditions/thyroid-cancer/diagnosis-treatment/drc-20354167

https://www.mayoclinic.org/diseases-conditions/thyroid-cancer/diagnosis-treatment/drc-20354167

Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Lung cancer in non-smokers accounts for roughly 25 percent of all lung cancer cases globally and is rising in India, particularly in women and younger adults. The most common subtype is adenocarcinoma, which carries EGFR, ALK or ROS1 mutations at far higher rates than smoker-related lung cancer. This distinction matters because mutation-positive disease responds to targeted oral therapies rather than conventional chemotherapy and the entire treatment approach differs from smoker lung cancer.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“Non-smoker lung cancer gets missed longer because neither the patient nor the physician suspects it. Molecular profiling at diagnosis is not optional in this group.”

Several environmental, genetic and molecular factors drive lung cancer in people who have never smoked.

• Indoor Air Pollution: Biomass fuel combustion from wood and crop residue used for cooking produces carcinogenic particulates and is the leading cause of non-smoker lung cancer in rural Indian women exposed through poorly ventilated kitchens over decades.

• EGFR and ALK Mutations: Spontaneous oncogenic mutations in EGFR, ALK and ROS1 genes occur without carcinogen exposure and lung cancer treatment at KIMS Hospital, Bangalore includes comprehensive molecular profiling at diagnosis for every non-smoker adenocarcinoma case before any systemic treatment is started.

• Radon Gas Exposure: Radon is a naturally occurring radioactive gas seeping from soil into enclosed spaces and is an underrecognised cause of lung cancer in non-smokers presenting without any obvious environmental or occupational risk factor.

• Secondhand Smoke: Prolonged secondhand smoke and occupational exposure to asbestos, diesel exhaust or arsenic compounds are established carcinogens that cause lung cancer in people who have never actively smoked throughout their lives.

Non-smoker lung cancer is biologically distinct from smoker-related lung cancer and requires a different diagnostic approach from the outset.

Treatment depends on stage, histological subtype and molecular mutation profile rather than smoking history.

• Targeted Therapy First: EGFR mutation-positive disease is treated with oral inhibitors like osimertinib or gefitinib as first-line therapy, producing significantly better progression-free survival and a far more tolerable side effect profile than platinum-based chemotherapy.

• Surgical Resection: Early-stage non-smoker lung cancer is surgically curable and robotic cancer surgery or video-assisted thoracoscopic lobectomy for Stage 1 and Stage 2 disease delivers equivalent outcomes to open thoracotomy with less pain and faster recovery.

• ALK and ROS1 Inhibitors: ALK-rearranged disease responds to alectinib or brigatinib and ROS1-rearranged disease responds to crizotinib or entrectinib, making comprehensive molecular profiling essential before any systemic treatment decision is confirmed.

• Immunotherapy Limits: Non-smoker adenocarcinomas typically have lower tumour mutational burden than smoker-related cancers, meaning PD-L1 checkpoint inhibitors produce less reliable responses and molecular profiling guides whether immunotherapy adds meaningful benefit.

Treatment decisions should always be made at tumour board with full molecular profiling results available and for more on navigating specialist cancer decisions, our blog on second opinion in cancer diagnosis covers this in detail.

Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to lung cancer surgery including robotic-assisted and video-assisted thoracoscopic resection at KIMS Hospital, Bangalore. He heads Oncology Services across Karnataka with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients with non-smoker lung cancer or incidental pulmonary findings are seen here with every case reviewed through tumour board. Call +91 8104310753 to book your consultation.

Reference Links-

1. National Cancer Institute — Lung Cancer Causes and Treatment
2. World Health Organization — Lung Cancer

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.